Finding Specialists and Paying for Services
- Introduction to Clinical Trials
- Research Findings
- Studies Enrolling Patients
- Research Collaborations
NCT01074970
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)or BRCA1/2 Mutations
Study identifier: NCT01074970
Full study details on clinicaltrials.gov
Name of PARP Inhibitor used in study:
PF-01367338 (Clovis)
Eligibility:
- Open to women with stage I-III breast cancer
- Open to women with a BRCA mutation or women with Triple Negative Breast Cancer
- This study is open to women who received standard neoadjuvant therapy for breast cancer but still have substantial residual disease at the time of surgery.
Type of study:
Phase II, randomized trial
Treatment:
Women who have already received neoadjuvant chemotherapy and have residual disease are randomized to receive the chemotherapy cisplatinum with or without the PARP Inhibitor PF-01367338.
Study sites:
Colorado
University of Colorado Cancer Center, Clinical Investigations Core
Aurora,CO80045
Contact: Sarah Witowsk 720-848-067
Florida
University of Miami, Sylvester Comprehensive Cancer Center
Miami, Florida 33136
Contact: Olga Machado-Aguero RN 305-243-9811
Contact: Eugene Ahn MD 305-243-6626
Indiana
Fort Wayne Onc & Hem, Inc
Fort Wayne, Indiana, 46815
Contact: Sreenivasa Nattam, M.. 260-484-8830
Contact: Lesllie Edgar, R.N. 260-484-8830 ledgar@fwmoh.com
Indiana University Cancer Center
Indianapolis, Indiana, 46202
Contact: Kathy Miller, M.D. 317-274-0920 kathmill@iupui.edu
Contact: Kerry Bridges 317-274-2552 kdbridge@iupui.edu
Community Regional Cancer Center
Indianapolis, Indiana, 46256
Contact: Sumeet Bhatia, M.D. 317-621-7104
Contact: Lisa McVicker, R.N. 317-621-7104
Horizon Oncology Center (IN - Lafayette)
Lafayette, Indiana, 47905
Contact: Wael Harb, M.D. 765-446-5111 wharb@thecaregroup.com
Contact: Linda Vaders, R.N. 765.446.5111 lvaders@thecaregroup.com
Community Hospital, Monroe Medical Associates
Munster, Indiana, 46321
Contact: Edwin Robin, M.D. 219-852-6456
Contact: Mary Shields, R.N. 219.852.6456 mshields@comhs.org
Northern Indiana Cancer Research Consortium
South Bend, Indiana, 46601
Contact: Jose Bufill, M.D. 574-234-5123
Contact: Susan Haithcox, R.N. (574) 647-7977 shaithcox@memorialsb.org
Missouri
Siteman Cancer Center
St. Louis, Missouri, 63110
Contact: Joel Picus, M.D. 314-747-1367
Contact: Henry Robinson 314-747-1375 hrobinso@im.wustl.edu
New Mexico
New Mexico Cancer Care Alliance
Albuquerque,New Mexico,87131
Contact: Kathy Anderson505-925-0405
Ohio
University Hospitals, Case Medical Center
Cleveland, Ohio, 44106
Contact: Tammy Kindwall-Keller, D.O. 216-844-5470
Contact: Courtney McGuire 216.844.5470
Pennsylvania
Bux-Mont Oncology Hematology Associates (FCCC) at Grand View Hospital
Fox Chase Cancer Center Extramural Research Program Recruiting
Rockledge, Pennsylvania, 19046
Contact: Judi Seldomridge, RN 215-728-7413 J_Seldomridge@fccc.edu
or Pat Parsons(215) 257-6858
PinnacleHealth Fox Chase Regional Cancer Center
Harrisburg, Pennsylvania
Contact: Kathy Litchfield717-782-4750
Tennessee
ACORN: The West Clinic
Memphis, Tennessee, 38138
Contact: Beverly B. Fryar RN, 901-683-0055 x1075
bfryar@westclinic.com
Virginia
Virginia Oncology Associates
Norfolk, Virginia, 23502
Contact: Wendi Gobhardt, RN, BSN, OCN757-213-5813
Page updated 02/08/13
Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.
This site has been made possible by a generous grant from Morphotek.